These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21257218)

  • 21. The Alleviation of Gut Microbiota-Induced Depression and Colitis in Mice by Anti-Inflammatory Probiotics NK151, NK173, and NK175.
    Yoo JW; Shin YJ; Ma X; Son YH; Jang HM; Lee CK; Kim DH
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease.
    Elian SD; Souza EL; Vieira AT; Teixeira MM; Arantes RM; Nicoli JR; Martins FS
    Benef Microbes; 2015; 6(3):277-86. PubMed ID: 25391346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bifidobacterium longum and VSL#3
    Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
    Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
    Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
    mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Bifidobacterium breve NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administration.
    Hayes CL; Natividad JM; Jury J; Martin R; Langella P; Verdu EF
    Benef Microbes; 2014 Mar; 5(1):79-88. PubMed ID: 24533977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice.
    Nishitani Y; Tanoue T; Yamada K; Ishida T; Yoshida M; Azuma T; Mizuno M
    Int Immunopharmacol; 2009 Nov; 9(12):1444-51. PubMed ID: 19733697
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Lee SY; Lee BH; Park JH; Park MS; Ji GE; Sung MK
    J Med Food; 2022 Feb; 25(2):146-157. PubMed ID: 35148194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis.
    Qiu X; Zhang M; Yang X; Hong N; Yu C
    J Crohns Colitis; 2013 Dec; 7(11):e558-68. PubMed ID: 23643066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity.
    Schmidt EG; Claesson MH; Jensen SS; Ravn P; Kristensen NN
    Inflamm Bowel Dis; 2010 Mar; 16(3):390-400. PubMed ID: 19714743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
    del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
    J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Probiotic therapy using live combined bifidobacterium, lactobacillus and enterococcus for experimental colitis in rats model].
    Wan YM; Zhu YQ; Xia B; Luo J
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):418-21. PubMed ID: 20646418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice.
    Lee HS; Han SY; Bae EA; Huh CS; Ahn YT; Lee JH; Kim DH
    Int Immunopharmacol; 2008 Apr; 8(4):574-80. PubMed ID: 18328449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1.
    Sideri A; Stavrakis D; Bowe C; Shih DQ; Fleshner P; Arsenescu V; Arsenescu R; Turner JR; Pothoulakis C; Karagiannides I
    Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(7):G591-604. PubMed ID: 25591865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multistep mechanism of probiotic bacterium, the effect on innate immune system.
    Amit-Romach E; Uni Z; Reifen R
    Mol Nutr Food Res; 2010 Feb; 54(2):277-84. PubMed ID: 19998380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
    Chu CC; Hou YC; Pai MH; Chao CJ; Yeh SL
    J Nutr Biochem; 2012 Sep; 23(9):1092-9. PubMed ID: 22137260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis.
    Preising J; Philippe D; Gleinser M; Wei H; Blum S; Eikmanns BJ; Niess JH; Riedel CU
    Appl Environ Microbiol; 2010 May; 76(9):3048-51. PubMed ID: 20228095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response.
    Thakur BK; Saha P; Banik G; Saha DR; Grover S; Batish VK; Das S
    Int Immunopharmacol; 2016 Jul; 36():39-50. PubMed ID: 27107798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice.
    Mendes MCS; Paulino DS; Brambilla SR; Camargo JA; Persinoti GF; Carvalheira JBC
    World J Gastroenterol; 2018 May; 24(18):1995-2008. PubMed ID: 29760543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.
    Singer M; Trugnan G; Chelbi-Alix MK
    Innate Immun; 2011 Aug; 17(4):365-74. PubMed ID: 20693187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
    Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
    Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.